Birkerød Høreklinik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.2% 16.1% 16.0% 18.7% 19.3%  
Credit score (0-100)  23 11 11 7 6  
Credit rating  BB BB BB B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  26.7 5.0 -28.0 7.1 -6.4  
EBITDA  26.7 5.0 -28.0 7.1 -6.4  
EBIT  26.7 5.0 -28.0 7.1 -6.4  
Pre-tax profit (PTP)  26.4 4.9 -28.0 7.1 -6.3  
Net earnings  20.6 3.8 -28.0 7.1 -6.3  
Pre-tax profit without non-rec. items  26.4 4.9 -28.0 7.1 -6.3  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  60.6 64.4 36.4 43.5 37.2  
Interest-bearing liabilities  0.0 0.0 2.2 0.0 0.0  
Balance sheet total (assets)  98.9 93.4 64.6 52.0 52.0  

Net Debt  -95.8 -93.4 -54.0 -52.0 -52.0  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  26.7 5.0 -28.0 7.1 -6.4  
Gross profit growth  0.0% -81.3% 0.0% 0.0% 0.0%  
Employees  1 1 0 0 0  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  99 93 65 52 52  
Balance sheet change%  0.0% -5.6% -30.8% -19.5% 0.1%  
Added value  26.7 5.0 -28.0 7.1 -6.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 -1.0 1.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  27.0% 5.2% -35.4% 12.3% -12.2%  
ROI %  44.1% 8.0% -54.3% 17.4% -15.7%  
ROE %  34.0% 6.1% -55.5% 17.9% -15.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  61.2% 68.9% 56.3% 83.8% 71.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -358.5% -1,871.9% 193.2% -727.6% 813.2%  
Gearing %  0.0% 0.0% 6.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.6 3.2 2.3 6.2 3.5  
Current Ratio  2.6 3.2 2.3 6.2 3.5  
Cash and cash equivalent  95.8 93.4 56.2 52.0 52.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  60.6 64.4 36.4 43.5 37.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  27 5 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  27 5 0 0 0  
EBIT / employee  27 5 0 0 0  
Net earnings / employee  21 4 0 0 0